… people in Canada, and with predictable results. Between 2011 and 2014, spending on drugs to treat opioid addiction rose a whopping 60 per cent, …
See all stories on this topic
Next article in issue: Neto2 Influences on Kainate Receptor Pharmacology and Function By continuing to browse this site you agree to us using cookies as described in About Cookies Author for correspondence: Panagiota Nikolaou, Department of Forensic Medicine and Toxicology, Faculty of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, Athens 115 27, Greece (fax +3021077160
See all stories on this topic
Conclusion: knowledge by health professionals of the harms caused by tobacco smoking contributed to their participation in anti-smoking programs, and led to a decline in the number of smokers at FSP-USP. The creation of 100% tobacco-free environments and programs to treat smokers who want to cease their addiction should be encouraged.RESUMO Introdução: as escolas de saúde pública, por sua pró
See all stories on this topic
Abstract
Four decades of concerted pharmacotherapy research has netted us three medications approved for the treatment of opioid addiction. The clinical pharmacology, safety, efficacy, and clinical use of these medications are familiar to most clinical researchers and clinicians in addiction medicine. Less common is an understanding of the social and political forces behind the choice of
See all stories on this topic
Authors: Eleonora Leucci, Roberto Vendramin, Marco Spinazzi, Patrick Laurette, Mark Fiers, Jasper Wouters, Enrico Radaelli, Sven Eyckerman, Carina Leonelli, Katrien Vanderheyden, Aljosja Rogiers, Els Hermans, Pieter Baatsen, Stein Aerts, Frederic Amant, Stefan Van Aelst, Joost van den Oord, Bart de Strooper, Irwin Davidson, Denis L. J. Lafontaine, Kris Gevaert, Jo Vandesompele, Pieter Mestdagh & J
See all stories on this topic
Be First to Comment